Cetrorelix Acetate CAS 120287-85-6

We are proud of our high quality product Cetrorelix Acetate CAS 120287-85-6. We can promise that Cetrorelix Acetate 120287-85-6 is highest purity in Chinese market. Cetrorelix Acetate is an injectable gonadotropin-releasing hormone (GnRH) antagonist. On the one hand, Cetrorelix Acetate is benefit to treating hormone-sensitive cancers of the prostate and breast (in pre-/perimenopausal women) and some benign gynaecological disorders (endometriosis, uterine fibroids and endometrial thinning). On the other hands, it show strongly powerful function in assisted reproduction to inhibit premature luteinizing hormone surges. We sincerely desire to establish close cooperation with you.

Thera. Category: An injectable gonadotropin-releasing hormone (GnRH) antagonist

Cas No.: 120287-85-6

Synonym: AC-(D-ALA[3-(2-NAPHTHYL)])-[D-PHE(4-CL)]-(D-ALA[3-(3-PYRIDYL)])-SER-TYR-(D-CIT)-LEU-ARG-PRO-D-ALA-OH;CETRORELIX;CETRORELIX ACID;Cetrorelix acetate;CETRIZINEDIHYDROCHLORIDE;N-Acetyl-3-(2-naphthalenyl)-D-Ala-4-chloro-D-Phe-3-(3-pyridyl)-D-Ala-L-Ser-L-Tyr-N5-(aminocarbonyl)-D-Orn-L-Leu-L-Arg-L-Pro-D-Ala-NH2;Cetrorelixum;Cetrorelixum [inn-latin]

Molecular Formula: C70H92ClN17O14

Molecular Weight: 1431.04

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Used to treat hormone-sensitive cancers of the prostate and breast (in pre-/perimenopausal women) and some benign gynaecological disorders (endometriosis, uterine fibroids and endometrial thinning)